COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,286 Articles (22,759 medRxiv, 8,527 bioRxiv)

Most recent first Previous |  Page 484: Articles 4831-4840  | Next

Rapid emergence of transmissible SARS-CoV-2 variants in mild community cases
Crone, M. A., Hakki, S., Zhou, J., Rosadas de Oliveira, C., Madon, K. J., Koycheva, A. V., Badhan, A., Jonnerby, J., Fenn, J., Kundu, R., Barnett, J. L., Nevin, S., Conibear, E., Derqui-Fernandez, N., Pillay, T. D., Varro, R., Luca, C., Quinn, V., Shazaad, A., Zambon, M., Barclay, W., Dunning, J., Freemont, P. S., Taylor, G. P., Lalvani, A.
10.1101/2023.02.15.23285923 — Posted: 2023-02-23
Excess burden of respiratory and abdominal conditions following COVID-19 infections during the ancestral and Delta variant periods in the United States: An EHR-based cohort study from the RECOVER Program
Varma, J. K., Zang, C., Carton, T. W., Block, J. P., Khullar, D. J., Zhang, Y., Weiner, M. G., Rothman, R. L., Schenck, E. J., Xu, Z., Lyman, K., Bian, J., Shenkman, E., Maughan, C., Castro-Baucom, L., OBrien, L., Wang, F., Kaushal, R.
10.1101/2023.02.15.23286012 — Posted: 2023-02-23
BRIEF COMMUNICATION High level of Anti SARS-Co-V2 RBD Antibody one year post booster vaccine hospital workers in Indonesia; Was second booster needed?
Muslimah, A. H., Tiara, M. R., Djauhari, H., Dewantara, H., Susandi, E., Indrati, A. R., Soeroto, A. Y., Alisjahbana, B., Wisaksana, R.
10.1101/2023.02.15.23285958 — Posted: 2023-02-23
Vaccine-induced correlate of protection against fatal COVID-19 in the old and frail during waves of neutralization resistant variants of concern.
Vikstrom, L., Fjallstrom, P., Gwon, Y.-D., Sheward, D. J., Wigren-Bystrom, J., Evander, M., Bladh, O., Widerstroem, M., Molnar, C., Rasmussen, G., Bennet, L., Aberg, M., Bjork, J., Tevell, S., Thalin, C., Blom, K., Klingstrom, J., Murrell, B., Ahlm, C., Normark, J., Johansson, A. F., Forsell, M.
10.1101/2023.02.16.23286009 — Posted: 2023-02-23
Has the COVID-19 pandemic ended or not? opinions from the public in the U.S.
Yang, Y.
10.1101/2023.02.15.23285880 — Posted: 2023-02-23
Utilizing Pre-trained Network Medicine Models for Generating Biomarkers, Targets, Re-purposing Drugs, and Personalized Therapeutic Regimes: COVID-19 Applications
Xiong, J.
10.1101/2023.02.21.527754 — Posted: 2023-02-22
Dynamics of Influenza A and SARS-CoV-2 coinfections during the COVID-19 pandemic in India
Ravikumar, S., Tamboli, E., Rahangdale, S., Salsekar, L., Tomar, S. S., Khairnar, K.
10.1101/2023.02.19.23285730 — Posted: 2023-02-22
REAL-WORLD EFFECTIVENESS OF NIRMATRELVIR/RITONAVIR ON COVID-19-ASSOCIATED HOSPITALIZATION PREVENTION: A POPULATION-BASED COHORT STUDY IN THE PROVINCE OF QUEBEC, CANADA
Kabore, J. L., Laffont, B., Diop, M., Tardif, M. R., Turgeon, A. F., Dumaresq, J., Luong, M.-L., Cauchon, M., Chapdelaine, H., Claveau, D., Brosseau, M., Haddad, E., Benigeri, M.
10.1101/2023.02.14.23285860 — Posted: 2023-02-22
Associations between SARS-CoV-2 infection and incidence of new chronic condition diagnoses: a systematic review
Gaudet, L. A., Pillay, J., Saba, S., Zakaria, D., Cheta, N., Gardiner, H., Shaver, L., Middleton, J., Tan, M., Vandermeer, B., Hartling, L.
10.1101/2023.02.21.23286181 — Posted: 2023-02-22
An empirical analysis of lay media coverage on influenza prevention pre- and post-COVID 19: Mask recommendations were previously rare, now ubiquitous.
Prasad, V., Brown, E., Haslam, A.
10.1101/2023.02.14.23285818 — Posted: 2023-02-22

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).